Cornercap Investment Counsel’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,153	Closed	-$223K	–	615
2022 Q3	$223K	Buy	+4,153	New	+$223K	0.04%	481